Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer immunotherapy and the management of side effects
Preethika Mahalingam, Thomas Newsom-Davis
Clinical Medicine (2023) Vol. 23, Iss. 1, pp. 56-60
Open Access | Times Cited: 12

Showing 12 citing articles:

Supramolecular Biomaterials for Cancer Immunotherapy
Huan Liang, Qingqing Lu, Jie Yang, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 27
Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors
Eun Mi Lee, Paula Jiménez‐Fonseca, Rocío Galán-Moral, et al.
Current Oncology (2023) Vol. 30, Iss. 10, pp. 9205-9216
Open Access | Times Cited: 13
Metallodrugs: From mere cytotoxic agents to immune modulators and checkpoint inhibitors
Muhammad Nafees, Muhammad Hanif, Piaoping Yang
Chinese Chemical Letters (2025), pp. 111013-111013
Closed Access
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
Helena T. Wu, Van Doren Hsu, Shwe Win, et al.
Visualized Cancer Medicine (2025) Vol. 6, pp. 1-1
Open Access
Analysis of YouTube Videos on Herbal Approaches Used in Coping with Cancer
Ferda Akyuz Ozdemir, Dilek Yıldırım
Seminars in Oncology Nursing (2025), pp. 151816-151816
Closed Access
Immunotherapy in the Treatment of Cancer: Today and Tomorrow
Gökçen Ömeroğlu Şi̇mşek
Current Molecular Biology Reports (2024)
Closed Access | Times Cited: 3
Construction of an immune-related gene prognostic model with experimental validation and analysis of immune cell infiltration in lung adenocarcinoma
Jialei Yang, Chao Tang, Chengxia Li, et al.
Oncology Letters (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 1
Decoding clinical trial jargon: helping people understand how safety and quality of life are assessed in cancer trials
Joel Burkholder, Amy Burkholder, Gissoo DeCotiis, et al.
Future Oncology (2024), pp. 1-6
Open Access
Current status and future prospective of breast cancer immunotherapy
Anurag S. Rathore, Narendra Chirmule, Rozaleen Dash, et al.
Advances in protein chemistry and structural biology (2024), pp. 293-326
Closed Access
Cancer immunotherapy and the management of side effects
Darran Mc Donald
Clinical Medicine (2023) Vol. 23, Iss. 2, pp. 190-190
Open Access | Times Cited: 1
Formalised curiosity
Anton Emmanuel
Clinical Medicine (2023) Vol. 23, Iss. 1, pp. 1-1
Open Access
Manejo en cuidado crítico de la toxicidad severa relacionada con la inmunoterapia en cáncer
Víctor Hugo Nieto Estrada, Daniel Franco, Anacaona Martínez del Valle, et al.
Medicina (2023) Vol. 45, Iss. 4, pp. 641-655
Open Access
Page 1

Scroll to top